Inicio › Enfermedad de obstrucción pulmonar crónica › Arizona
Ensayos clínicos de Enfermedad de obstrucción pulmonar crónica en Arizona
16 estudios sobre Enfermedad de obstrucción pulmonar crónica buscan participantes en Arizona.
Ciudades en Arizona
Texto oficial del estudio (inglés)
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- Chandler Clinical Research Trials- Site Number : 8400025, Chandler
- Pulmonary Associates - Phoenix - East Bell Road- Site Number : 8400114, Phoenix
- Epic Medical Research - Surprise- Site Number : 8400096, Surprise
ReclutandoFase 3
Edades de 40 a 80 · Todos los sexos · Actualizado el 22 sept 2026 · NCT07190209An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
- Banner University Medical Center, Phoenix
Reclutando
Edades de 40 a 80 · Todos los sexos · Actualizado el 17 sept 2026 · NCT06035120Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Tucson Clinical Research Institute- Site Number : 8400006, Tucson
ReclutandoFase 3
Edades de 40 a 80 · Todos los sexos · Actualizado el 15 sept 2026 · NCT07190222A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, Phoenix
- Research Site, Phoenix
- Research Site, Phoenix
ReclutandoFase 2
Edades de 40 en adelante · Todos los sexos · Actualizado el 9 sept 2026 · NCT07082738Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
- University of Arizona- Tuscon, Tucson
ReclutandoFase 2
Edades de 40 en adelante · Todos los sexos · Actualizado el 4 sept 2026 · NCT07059091A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Phoenix
- Research Site, Scottsdale
ReclutandoFase 3
Edades de 40 a 80 · Todos los sexos · Actualizado el 3 sept 2026 · NCT06878261A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, Phoenix
- Research Site, Phoenix
ReclutandoFase 3
Edades de 40 a 80 · Todos los sexos · Actualizado el 3 sept 2026 · NCT06883305A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- Chandler Clinical Trials, Chandler
- Pulmonary Associates, PA, Phoenix
ReclutandoFase 2/3
Edades de 35 a 80 · Todos los sexos · Actualizado el 31 ago 2026 · NCT07363694A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Gilbert
- Research Site, Mesa
- Research Site, Mesa
- y 2 más
ReclutandoFase 3
Edades de 40 a 80 · Todos los sexos · Actualizado el 26 ago 2026 · NCT06283966A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
- GC2501 Study Site 102, Phoenix
- GC2501 Study Site 107, Scottsdale
ReclutandoFase 3
Edades de 18 a 80 · Todos los sexos · Actualizado el 11 ago 2026 · NCT07555483To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
- DM Clinical Research - Phoenix, Phoenix
ReclutandoFase 2
Edades de 40 a 85 · Todos los sexos · Actualizado el 7 ago 2026 · NCT07684820STRIVE Post-Market Registry Study
- Dignity Health St. Joseph's Hospital and Medical Center, Phoenix
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 3 ago 2026 · NCT04302272SPIROMICS Study of Early COPD Progression (SOURCE)
- Mayo Clinic Arizona, Scottsdale
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 30 a 55 · Todos los sexos · Actualizado el 3 jun 2026 · NCT05033990Pulmonary Rehabilitation for Rural Patients With COPD
- Mayo Clinic in Arizona, Scottsdale
Reclutando
Edades de 40 en adelante · Todos los sexos · Actualizado el 7 may 2026 · NCT06847061Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
- Banner Health, Gilbert
Reclutando
Edades de 40 a 84 · Todos los sexos · Actualizado el 24 abr 2026 · NCT06891755myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
- Honor Health, Scottsdale
Reclutando
Edades de 30 en adelante · Todos los sexos · Actualizado el 6 feb 2025 · NCT05204888De ClinicalTrials.gov, datos obtenidos el 30 sept 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.